Tyler N Bennett

Array ( [id] => 4404285 [patent_doc_number] => 06299875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Methods to block IGE binding to cell surface receptors of mast cells' [patent_app_type] => 1 [patent_app_number] => 9/090375 [patent_app_country] => US [patent_app_date] => 1998-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6931 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/299/06299875.pdf [firstpage_image] =>[orig_patent_app_number] => 090375 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4316605 [patent_doc_number] => 06242577 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Isolation and use fibronectin receptor' [patent_app_type] => 1 [patent_app_number] => 9/082229 [patent_app_country] => US [patent_app_date] => 1998-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 5808 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242577.pdf [firstpage_image] =>[orig_patent_app_number] => 082229 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4067639 [patent_doc_number] => 06068841 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-30 [patent_title] => 'Antibodies to Fas-L for treatment of hepatitis' [patent_app_type] => 1 [patent_app_number] => 9/065059 [patent_app_country] => US [patent_app_date] => 1998-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 5 [patent_no_of_words] => 10786 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/068/06068841.pdf [firstpage_image] =>[orig_patent_app_number] => 065059 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403474 [patent_doc_number] => 06270997 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'DNA encoding porcine complement inhibitor' [patent_app_type] => 1 [patent_app_number] => 8/981234 [patent_app_country] => US [patent_app_date] => 1998-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5549 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270997.pdf [firstpage_image] =>[orig_patent_app_number] => 981234 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7027812 [patent_doc_number] => 20010014327 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-16 [patent_title] => 'CHIMERIC ANTIBODIES FOR DELIVERY OF ANTIGENS TO SELECTED CELLS OF THE IMMUNE SYSTEM' [patent_app_type] => new [patent_app_number] => 08/973518 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 10184 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20010014327.pdf [firstpage_image] =>[orig_patent_app_number] => 08973518 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4411912 [patent_doc_number] => 06265565 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-24 [patent_title] => 'Prostate associated Ets protein' [patent_app_type] => 1 [patent_app_number] => 9/055113 [patent_app_country] => US [patent_app_date] => 1998-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23081 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/265/06265565.pdf [firstpage_image] =>[orig_patent_app_number] => 055113 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4364159 [patent_doc_number] => 06274314 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Diagnostic assay for the modified nucleosides pseudouridine, 7-methyladenosine, or 1-methyladenosine' [patent_app_type] => 1 [patent_app_number] => 9/053913 [patent_app_country] => US [patent_app_date] => 1998-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5841 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274314.pdf [firstpage_image] =>[orig_patent_app_number] => 053913 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4158238 [patent_doc_number] => 06107473 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-22 [patent_title] => 'Kringle-related clone HTHBZ47' [patent_app_type] => 1 [patent_app_number] => 9/039609 [patent_app_country] => US [patent_app_date] => 1998-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10692 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/107/06107473.pdf [firstpage_image] =>[orig_patent_app_number] => 039609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4294077 [patent_doc_number] => 06235872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Proapoptotic peptides dependence polypeptides and methods of use' [patent_app_type] => 1 [patent_app_number] => 9/041886 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 17162 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235872.pdf [firstpage_image] =>[orig_patent_app_number] => 041886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4129496 [patent_doc_number] => 06146845 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-11-14 [patent_title] => 'Polynucleotides encoding a sialoadhesin family member-2 (SAF-2)' [patent_app_type] => 1 [patent_app_number] => 9/038832 [patent_app_country] => US [patent_app_date] => 1998-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11634 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/146/06146845.pdf [firstpage_image] =>[orig_patent_app_number] => 038832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4043589 [patent_doc_number] => 05912128 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-06-15 [patent_title] => 'Human ena/VASP-like protein splice variant' [patent_app_type] => 1 [patent_app_number] => 9/026587 [patent_app_country] => US [patent_app_date] => 1998-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 22419 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/912/05912128.pdf [firstpage_image] =>[orig_patent_app_number] => 026587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4362799 [patent_doc_number] => 06255471 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-07-03 [patent_title] => 'CRFG-1b, a target and marker for chronic renal failure' [patent_app_type] => 1 [patent_app_number] => 9/020465 [patent_app_country] => US [patent_app_date] => 1998-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11109 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/255/06255471.pdf [firstpage_image] =>[orig_patent_app_number] => 020465 [rel_patent_id] =>[rel_patent_doc_number] =>)